Clinical applications of proton MR spectroscopy in oncology

Technology in Cancer Research and Treatment

Volumn 1, Issue 1, 2002, Pages 17-28

  Kwock, Lester ^a   Smith, J Keith ^a   Castillo, Mauricio ^a   Ewend, Matthew G ^a   Cush, Sharon ^a   Hensing, Thomas ^a   Varia, Mahesh ^a   Morris, David ^a   Bouldin, Thomas W ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; CHOLINE; CITRIC ACID; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; TAURINE;

BRAIN TUMOR; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL EXAMINATION; DIAGNOSTIC IMAGING; GLIOMA; HUMAN; IMAGE ANALYSIS; MEDICAL SPECIALIST; METABOLITE; ONCOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TECHNIQUE; TUMOR; TUMOR DIAGNOSIS;

EID: 0037997009     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460200100103     Document Type: Review

References (57)

1. Castillo, M., and Kwock, L. Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. Topics Mag. Res. Imaging 10, 104-113 (1999).
2. Taylor, J.S., Langston, J.W., Reddick W.E., Kingsley, P.B., et al. Clinical value of proton magnetic resonance spectroscopy for differentiating recur rent or residual brain tumor from delayed cerebral necrosis. Int. J. Radiation Oncology Biol. Phys. 36, 1251-1261 (1996).
3. Castillo, M. (ed.), Proton MR Spectroscopy of the Brain, Neuroimaging Clinics of North America, Vol. 18 (4), W.B. Saunders Co., Philadelphia, pp. 713-926.(1998)
4. Burtscher, I.M., and Holtas, S. Proton MR spectroscopy in clinical routine. J. Magn. Reson. Imaging 13, 560-567, (2001)
5. Vigneron, D.B., Nelson, S.J., and Kurhanewicz, J., Proton chemical shift imaging of cancer, In Magnetic Resonance Imaging of the Body, Chapter 12, 3rd edition, C.B. Higgins, H. Hricak, and C.A. Helms (eds.), Lippincott-Raven Press, New York, pp. 205-220. (1997)
6. Kvistad, K.A., Bakken, I.J., Gribbestad, I.S., et al., Characterization of neo plastic and normal human breast tissues with in vivo H-1 MR spectroscopy. J. Magn. Reson. Imaging 10, 159-164 (1999).
7. Allen, J.R., Prost, R.W., Griffith, O.W., et al., in vivo proton (H-1) magnet ic resonance spectroscopy of cervical carcinoma. Am. J. Clin. Oncol. 24, 522-529 (2001).
8. Kwock, L., Localized MR spectroscopy: Basic Principles. Neuroimaging Clinics of North America 8, 713-732 (1998).
9. Greutter, R., Weisdorf, S.A., Rajanayagan, V., et al. Resolution improve ments in "in vivo" NMR spectra with increased magnetic field strength. J. Magn. Reson. 135, 260-264 (1998).
10. Fulham, M.J., Bizzi, A., Dietz, M.J., et. al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology 185, 675-686 (1992).
11. Zeisel, S.H. Choline, A nutrient that is involved in the regulation of cell proliferation, cell death and cell transformation. Adv. Exp. Med. Biol. 399, 131-141 (1996).
12. Miller, B.L., Chang, L., Booth, R., et al. in vivo H-1 MRS choline: Correlation with In Vitro chemistry/histology. Life Sciences 58, 1929-1935 (1996).
13. Shimizu, H., Kumabe, T., Shirane, R., and Yoshimoto, T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. Am. J. Neuroradiol. 21, 659-665 (2000).
14. Smith, J.K., Kwock, L., and Castillo, M. Effects of contrast material on sin gle-volume proton MR spectroscopy. Am. J. Neuroradiol. 21, 1084-1089, (2000).
15. Somorjai, R.L., Nikulin, A.E., Pizzi, N., et al. Computerized concensus diagnosis: A classification strategy for the robust analysis of MR spectra. I. Application to H-1 spectra of thyroid neoplasms. Magn. Reson. Med. 33, 257-263 (1995).
16. Preul, M.C., Caramanos, Z., Collins, D.L., et al. Linear discriminant analy sis based on proton MR spectroscopic imaging of human brain tumors improves pre-operative diagnosis. Nature Med. 2, 323-325 (1996).
17. Wallace, J.C., Raaphorst, G.P., Somorjai, R.L., et al. Classification of H-1 MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magn. Reson. Med. 38, 569-576 (1997).
18. Lean, C.L., Newland, R.C., Ende, D.A., et al. Assessment of human col orectal biopsies by H-1 MRS:Correlation with Histopathology. Magn. Reson. Med. 30, 525-533 (1993).
19. Sijens, P.E., van Dijk, P., Oudkerk, M. Correlation between choline level and Gd-DPTA enhancement in patients with brain metastases of mammary carcinoma. Magn. Reson. Med. 32, 549-555 (1994).
20. Mackinnon, W.B., Barry, P.A., Malycha,P.L., et al. Fine-needle biopsy specimens of benign breast lesions distinquished from invasive cancer ex Vivo with proton MR spectroscopy. Radiology 204, 661-666 (1997).
21. Mukherji, S.K., Schiro, S., Castillo, M., et al. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: In vitro and in vivo studies. Am. J. Neuroradiol. 18, 1057-1072 (1997).
22. Hendrikus G., Krouwer, J., Kim, T.A., et al. Single-voxel proton MR spectroscopy of non-neoplastic brain lesions suggestive of a neoplasm. Am. J. Neuroradiol. 19, 1695-1703 (1998).
23. Bitsch, A., Bruhn, H., Vougioukas, V., et al. Inflammatory CNS Demyelination: Histopatholigic correlation with in vivo quantitative proton MR spectroscopy. Am. J. Neuroradiol. 20, 1619-1627 (1999).
24. Martin, A.J., Liu, H., Hall, W.A., and Truwit, C.L. Preliminary assessement of turbo spectroscopic imaging for targeting in brain biopsy. Am. J. Neuroradiol. 22, 959-968 (2001).
25. Castillo, M., Scatliff, J.H., Bouldin,T.W., and Suzuki, K. Radiologicpathologic correlation: Intracranial astrocytoma. Am. J. Neuroradiol. 13, 1609-1616 (1992).
26. Castillo, M., Kwock, L., Scatliff, J., and Mukherji, S.K. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. MR1 Clinics of North America 6, 1-19 (1998).
27. Tien R.D., Lai P.H., Smith J.S., and Lazeyras F. Single voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR 167, 201-209 (1996).
28. Castillo, M., Smith, J.K., and Kwock, L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. Am. J. Neuroradiol. 21, 1645-1649 (2000).
29. Dowling, C., Bollen, A.W., Noworolski, S.M., et al. Preoperative proton MR spectroscopic imaging of brain tumors: Correlation with histopatholog ic analysis of resection specimens. Am. J. Neuroradiol. 22, 604-612 (2001).
30. Liu, H., Hall, W.A., Martin, A.J., and Truwit, C.L. An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery. J. Magn. Reson. Imaging 14, 1-7 (2001).
31. Kondziolka, D., Flickinger, J.C., Bissonette, D.J., et al. Survival benefits of sterotactical radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41, 776-785 (1997).
32. Watanabe, M., Tanaka, R., and Takeda, N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34, 463-469 (1992).
33. Graves, E.E., Nelson, S.J., Vigneron, D.B., et al. A preliminary study of the prognostic value of proton MR spectroscopic imaging in gamma knife radio surgery of recurrent malignant gliomas. Neurosurgery 46, 319-328 (2000).
34. Rubin, D.B. and Griem, M.L., The histopathology of irradiated endotheli um, In: The radiation biology of the vascular endotheli um, D.B. Rubin (ed.), CRC Press, Boca Raton, FL, pp. 13-38. (1998)
35. Graves, E.E., Nelson, S.J., Vigneron, D.B., et al. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radio surgery Am. J. Neuroradiol. 22, 613-624 (2001).
36. Kuesel, A.C., Sutherland, G.R., Halliday, W., and Smith, I.C.P. H-1 MRS of high grade astrocytomas:mobile lipid accumulation in necrotic tissue. NMR Biomed. 7, 149-155 (1994).
37. Negendank, W., and Sauter,r R. Intratumoral lipids in H-1 MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. Anticancer Res. 16, 1533-1538 (1996).
38. Tomoi, M., Kimura, H., Yoshida, M., et al. Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy. Invest. Radiol. 32, 288-296 (1997).
39. Bizzi, A., Movsas, B., Tedeschi, G., et al. Response of non-Hodgkin lym phoma to radiation therapy: Early and long-term assessment with H-1 MR spectroscopic imaging. Radiology 194, 271-276 (1995).
40. Tzika, A.A., Zurakowski, D., Poussaint, T.Y., et al. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiol. 43, 169-177 (2001).
41. Kwock, L., Castillo, M., and Smith, J.K. Comparison of proton MR spec tral patterns of glioblastoma multiforme (GBM) versus metastatic brain tumors, Presented at the 37th Meeting of The American Society of Neuroradiology 1999, San Diego, CA, p. 58 (Book of Abstracts).
42. Ishimaru, H., Morikawa, M., Iwanaga, S., et al. Differentiation between high-grade glioma and metastatic brain tumor using singlevoxel proton MR spectroscopy Eur. Radiol. 11, 1784-1791 (2001).
43. Ernst, R.R., Bodenhausen, G., and Wokaun, A. Principles of NMR, in one and two dimensions, Oxford, Oxford Publications, 1987.
44. Traficante, D.D. The nature of the second dimension in 2D NMR. Concepts in Magnetic Resonance 1, 7-13 (1989).
45. Derome, A.E. Homonuclear Shift Correlation, in: Modern NMR Techniques for Chemistry Research, Pergamon Press, Oxford, pp. 183-244 (1987).
46. Lean, C.L., Mackinnon, W.B., and Mountford, C.E. Fucose in H-1 COSY spectra of plasma membrane fragments shed from human malignant col erectal cells. Magn. Reson. Med. 20, 306-311 (1991).
47. Isselbacher, K.J. Increased uptake of amino acids and 2-deoxy-D-glucose by virus-transformed cells in culture. Proc. Natl. Acad. Sci. USA 69, 585-589 (1972).
48. Russell, P., Lean, C.L., Delbridge, L., May, G.L., et al. Proton magnetic resonance and human thyroid neoplasia I: Discrimination between benign and malignant neoplasms. Am. J. Medicine 96, 383-388 (1994).
49. Mountford, C.E., Lean, C.L, MacKinnon, W.B., and Russell, P. The use of proton MR in cancer pathology, In: Annual Reports on NMR Spectroscopy (Webb G.A., ed.), 27, 173-216 (1993).
50. Thomas, M.A., Binesh, N., Yue, K., and DeBruhl, N. Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer. J. Magn. Reson. Medicine 14, 181-186 (2001).
51. Swanson, M.G., Vigneron, D.B., Tran, T-K.C., et. al. Single-voxel over sampled J-resolved spectroscopy of in vivo human prostate tissue. Magn. Reson. Medicine 45, 973-980 (2001).
52. Thomas, M.A., Ryner, L.N., Mehta, M.P., et al. Localized 2D J-resolved H-1 MR spectroscopy of human brain tumors in vivo. J. Magn. Reson. Imaging 6, 453-459 (1996).
53. Ross, B.D., Ben-Yoseph, O., and Chenevert, T.L. in vivo magnetic resonance imaging and spectroscopy: Application to brain tumors. Advances in Neurochemistry 8, 145-177 (1997).
54. Hugg, J.W., Matson, G.B., Tweig, D.B. Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. Magn. Reson. Imaging 10, 227-243 (1992).
55. Ng, T.C., Grundfest, S., Vijayakumar, S., et. al. Therapeutic response of breast carcinoma montitored by P-31 MRS in Situ. Magn. Reson. Medicine 10, 125-134 (1989).
56. McSheehy, P.M.J. and Griffiths, J.R. F-19 MRS of fluoropyrimidine chemotherapy. A review. NMR Biomed. 2, 133-140 (1989).
57. London, R.E. C-13 Labeling in studies of metabolic regulation. Prog. NMR Spectroscopy 20, 331-383 (1988).